Outsourcing-pharma14h
AbbVie announces positive phase 3 results for Parkinson’s drug
The oral, specific dopamine agonist met its primary endpoint in the trial, which is the second of three phase 3 trials ...
Outsourcing-pharma14h
Pfizer withdraws sickle cell disease drug Oxbryta amid safety concerns
The US big pharma company Pfizer has voluntarily withdrawn the oral sickle cell disease treatment Oxbryta from the market and ...
Outsourcing-pharma2d
FDA greenlights first treatment for Niemann-Pick disease type C
The small molecule drug arimoclomol (Miplyffa) has got the green light from the U.S. Food and Drug Administration (FDA) for ...
Outsourcing-pharma2d
Biohaven’s real-world trial shows positive results for spinocerebellar ataxia drug
The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will ...